Iron-Containing Supplements and Drugs: Label Warning Statement Requirements; Small Entity Compliance Guide; Availability

NonrulemakingNoticeFDA-1997-D-0056-0003
Comments
0
Awaiting comments
Deadline
--
Net supportiSupport minus oppose · campaigns included
Document

Details

The document's own metadata, straight from regulations.gov.

Posted
Oct 21, 2003
Comment period
Oct 16, 2003 – ?
Agency
Food and Drug Administration (FDA)
FR Doc
03-26189
Analysis

Overview

No comments yet.

Comments

Explorer

Every mirrored comment — filter by stance, campaign, or issue.

Filter:

No comments match.